KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesProfit After TaxShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ADTRAN Holdings (ADTN) Research & Development (2016 - 2023)

ADTRAN Holdings has reported Research & Development over the past 15 years, most recently at $70.6 million for Q2 2023.

  • Quarterly Research & Development rose 166.41% to $70.6 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $150.2 million through Jun 2023, up 41.23% year-over-year, with the annual reading at $173.8 million for FY2022, 59.89% up from the prior year.
  • Research & Development was $70.6 million for Q2 2023 at ADTRAN Holdings, up from $26.5 million in the prior quarter.
  • Over five years, Research & Development peaked at $70.6 million in Q2 2023 and troughed at $26.5 million in Q1 2022.
  • The 5-year median for Research & Development is $27.9 million (2021), against an average of $31.5 million.
  • Year-over-year, Research & Development decreased 14.49% in 2020 and then surged 166.41% in 2023.
  • A 5-year view of Research & Development shows it stood at $30.7 million in 2019, then dropped by 10.27% to $27.5 million in 2020, then decreased by 3.41% to $26.6 million in 2021, then dropped by 0.26% to $26.5 million in 2022, then soared by 166.41% to $70.6 million in 2023.
  • Per Business Quant, the three most recent readings for ADTN's Research & Development are $70.6 million (Q2 2023), $26.5 million (Q2 2022), and $26.5 million (Q1 2022).